Dermapharm Holding SE (DB:DMP) agreed to acquire Euromed S.A. from The Riverside Company for approximately €200 million on November 18, 2018. Euromed S.A. reported revenues of €57.1 million in 2017. The transaction is subject to approval from the antitrust authorities. The transaction is expected to be completed at the beginning of 2019. Christophe Balthazard, Fabian Beullekens, Clemence Colson, Ilya Vaneev, Javier Alonso de Armino, Bosco De Checa, Inigo del Val, Anunciada Delgado, Enrique Diaz-Maurino, Santiago Gil-Gruart, Marina Jimenez, Zoila Jimenez, Gonzalo Mateos, Aixa Pol, Alejandra Puig and Lucia Sainz of Allen & Overy LLP acted as legal advisors for Riverside. Ernst & Young acted as accountant in the transaction. Rothschild & Co, Fidentiis and Ferber & Co. acted as financial advisors to Riverside. Alejandro Fernández de Araoz and Vicente Paramio of Araoz & Rueda acted as a legal advisors to Dermapharm. Deloitte acted as financial advisor and Pöllath + Partners acted as legal advisor for Dermapharm. Boltendahl International Partners acted as the financial advisor to Dermapharm. Dermapharm Holding SE (DB:DMP) completed the acquisition of Euromed S.A. from The Riverside Company on January 3, 2019.